InvestorsHub Logo
Followers 8
Posts 1295
Boards Moderated 0
Alias Born 04/13/2016

Re: weasel6667 post# 46405

Wednesday, 09/25/2019 12:24:18 PM

Wednesday, September 25, 2019 12:24:18 PM

Post# of 232198
I think my point was pretty close to what you are just now realizing. The potential value is not based on the SP. Your comment that the value of this company is the market cap and Leronlimab is worthless is incorrect. Companies buying/partnering other companies are mostly paying for the product value, not the other companies SP value, especially in this case. Thinks about it, why would any company partner with another? Because they see a potential for profit from the other companies product - hence the value being based on that potential. You can dis-agree all you want, but the Mgmt of this company is clearly negotiating based on this, not the SP.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News